The DOI matches its Crossref record; 379 of the 379 references it cites were found in a registry or an index.
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer
Open accessAbstract
Introduction: Breast cancer remains a significant scientific, clinical and societal challenge. This gap analysis has reviewed and critically assessed enduring issues and new challenges emerging from recent research, and proposes strategies for translating solutions into practice. Methods: More than 100 internationally recognised specialist breast cancer scientists, clinicians and healthcare professionals collaborated to address nine thematic areas: genetics, epigenetics and epidemiology; molecular pathology and cell biology; hormonal influences and endocrine therapy; imaging, detection and screening; current/novel therapies and biomarkers; drug resistance; metastasis, angiogenesis, circulating tumour cells, cancer ‘stem’ cells; risk and prevention; living with and managing breast cancer and its treatment. The groups developed summary papers through an iterative process which, following further appraisal from experts and patients, were melded into this summary account. Results: The 10 major gaps identified were: (1) understanding the functions and contextual interactions of genetic and epigenetic changes in normal breast development and during malignant transformation; (2) how to implement sustainable lifestyle changes (diet, exercise and weight) and chemopreventive strategies; (3) the need for tailored screening approaches including clinically actionable tests; (4) enhancing knowledge of molecular drivers behind breast cancer subtypes, progression and metastasis; (5) understanding the molecular mechanisms of tumour heterogeneity, dormancy, de novo or acquired resistance and how to target key nodes in these dynamic processes; (6) developing validated markers for chemosensitivity and radiosensitivity; (7) understanding the optimal duration, sequencing and rational combinations of treatment for improved personalised therapy; (8) validating multimodality imaging biomarkers for minimally invasive diagnosis and monitoring of responses in primary and metastatic disease; (9) developing interventions and support to improve the survivorship experience; (10) a continuing need for clinical material for translational research derived from normal breast, blood, primary, relapsed, metastatic and drug-resistant cancers with expert bioinformatics support to maximise its utility. The proposed infrastructural enablers include enhanced resources to support clinically relevant in vitro and in vivo tumour models; improved access to appropriate, fully annotated clinical samples; extended biomarker discovery, validation and standardisation; and facilitated cross-discipline working. Conclusions: With resources to conduct further high-quality targeted research focusing on the gaps identified, increased knowledge translating into improved clinical care should be achievable within five years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Radiomics: extracting more information from medical images using advanced feature analysis
Lambin, P., Rios-Velazquez, E., Leijenaar, R., Carvalho, S., van Stiphout, R. G. P. M., Granton, P., Zegers, C. M. L., Gillies, R., Boellard, R., Dekker, A., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.11.036 · Cited by 6,084
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2011) · The Lancet · doi:10.1016/s0140-6736(11)60993-8 · Cited by 3,075
Giuliano, A. E. (2011) · JAMA · doi:10.1001/jama.2011.90 · Cited by 2,942
Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
Baselga, J., Campone, M., Piccart, M., Burris, H. A., Rugo, H. S., Sahmoud, T., Noguchi, S., Gnant, M., Pritchard, K. I., Lebrun, F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109653 · Cited by 2,863
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Aebi, S., Davidson, T., Gruber, G., & Castiglione, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq159 · Cited by 2,842
Metastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2622 · Cited by 2,649
Paik, S., Tang, G., Shak, S., Kim, C., Baker, J., Kim, W., Cronin, M., Baehner, F. L., Watson, D., Bryant, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7985 · Cited by 2,579
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
Baselga, J., Cortés, J., Kim, S.-B., Im, S.-A., Hegg, R., Im, Y.-H., Roman, L., Pedrini, J. L., Pienkowski, T., Knott, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113216 · Cited by 2,532
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., et al. (2013) · Science · doi:10.1126/science.1228522 · Cited by 2,476
Gianni, L., Pienkowski, T., Im, Y.-H., Roman, L., Tseng, L.-M., Liu, M.-C., Lluch, A., Staroslawska, E., de la Haba-Rodriguez, J., Im, S.-A., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70336-9 · Cited by 2,374
EFFECT OF PSYCHOSOCIAL TREATMENT ON SURVIVAL OF PATIENTS WITH METASTATIC BREAST CANCER
Spiegel, D., Kraemer, H., Bloom, J., & Gottheil, E. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91551-1 · Cited by 2,353
Audeh, M. W., Carmichael, J., Penson, R. T., Friedlander, M., Powell, B., Bell-McGuinn, K. M., Scott, C., Weitzel, J. N., Oaknin, A., Loman, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60893-8 · Cited by 2,279
Self-citationDifferential oestrogen receptor binding is associated with clinical outcome in breast cancer
Ross-Innes, C. S., Stark, R., Teschendorff, A. E., Holmes, K. A., Ali, H. R., Dunning, M. J., Brown, G. D., Gojis, O., Ellis, I. O., Green, A. R., et al. (2012) · Nature · doi:10.1038/nature10730 · Cited by 2,173
Self-citationEarly Breast Cancer Trialists' Collaborative Group (EBCTCG) (2012) · The Lancet · doi:10.1016/s0140-6736(11)61625-5 · Cited by 2,089
Davies, C., Pan, H., Godwin, J., Gray, R., Arriagada, R., Raina, V., Abraham, M., Alencar, V. H. M., Badran, A., Bonfill, X., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61963-1 · Cited by 2,044
Dowsett, M., Nielsen, T. O., A'Hern, R., Bartlett, J., Coombes, R. C., Cuzick, J., Ellis, M., Henry, N. L., Hugh, J. C., Lively, T., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr393 · Cited by 1,977
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Shah, S. P., Roth, A., Goya, R., Oloumi, A., Ha, G., Zhao, Y., Turashvili, G., Ding, J., Tse, K., Haffari, G., et al. (2012) · Nature · doi:10.1038/nature10933 · Cited by 1,967
Self-citationLong-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
Whelan, T. J., Pignol, J.-P., Levine, M. N., Julian, J. A., MacKenzie, R., Parpia, S., Shelley, W., Grimard, L., Bowen, J., Lukka, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906260 · Cited by 1,878
Stromal gene expression predicts clinical outcome in breast cancer
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Omeroglu, G., Meterissian, S., Omeroglu, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1764 · Cited by 1,687
Loi, S., Sirtaine, N., Piette, F., Salgado, R., Viale, G., Van Eenoo, F., Rouas, G., Francis, P., Crown, J. P. A., Hitre, E., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0902 · Cited by 1,632
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Murtaza, M., Dawson, S.-J., Tsui, D. W. Y., Gale, D., Forshew, T., Piskorz, A. M., Parkinson, C., Chin, S.-F., Kingsbury, Z., Wong, A. S. C., et al. (2013) · Nature · doi:10.1038/nature12065 · Cited by 1,624
Choosing the right cell line for breast cancer research
Holliday, D. L., & Speirs, V. (2011) · Breast Cancer Research · doi:10.1186/bcr2889 · Cited by 1,541
Self-citationAlbain, K. S., Barlow, W. E., Shak, S., Hortobagyi, G. N., Livingston, R. B., Yeh, I.-T., Ravdin, P., Bugarini, R., Baehner, F. L., Davidson, N. E., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70314-6 · Cited by 1,407
Differential Oestrogen Receptor Binding is Associated with Clinical Outcome in Breast Cancer
Stark, R. (2012) · Lecture Notes in Computer Science · doi:10.1007/978-3-642-29627-7_30 · Cited by 1,403
Goldhirsch, A., Ingle, J. N., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp322 · Cited by 1,374
Naba, A., Clauser, K. R., Hoersch, S., Liu, H., Carr, S. A., & Hynes, R. O. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.014647 · Cited by 1,354
Speck, R. M., Courneya, K. S., Mâsse, L. C., Duval, S., & Schmitz, K. H. (2010) · Journal of Cancer Survivorship · doi:10.1007/s11764-009-0110-5 · Cited by 1,352
Three-dimensional culture models of normal and malignant breast epithelial cells
Lee, G. Y., Kenny, P. A., Lee, E. H., & Bissell, M. J. (2007) · Nature Methods · doi:10.1038/nmeth1015 · Cited by 1,336
Tumor Self-Seeding by Circulating Cancer Cells
Kim, M.-Y., Oskarsson, T., Acharyya, S., Nguyen, D. X., Zhang, X. H.-F., Norton, L., & Massagué, J. (2009) · Cell · doi:10.1016/j.cell.2009.11.025 · Cited by 1,335
Baselga, J., Bradbury, I., Eidtmann, H., Di Cosimo, S., de Azambuja, E., Aura, C., Gómez, H., Dinh, P., Fauria, K., Van Dooren, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61847-3 · Cited by 1,317
Hughes, K. S., Schnaper, L. A., Bellon, J. R., Cirrincione, C. T., Berry, D. A., McCormick, B., Muss, H. B., Smith, B. L., Hudis, C. A., Winer, E. P., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2615 · Cited by 1,310
Sequence analysis of mutations and translocations across breast cancer subtypes
Banerji, S., Cibulskis, K., Rangel-Escareno, C., Brown, K. K., Carter, S. L., Frederick, A. M., Lawrence, M. S., Sivachenko, A. Y., Sougnez, C., Zou, L., et al. (2012) · Nature · doi:10.1038/nature11154 · Cited by 1,179
Non-Invasive Analysis of Acquired Resistance to Cancer Therapy By Sequencing of Plasma Dna
(2014) · Annals of Oncology · doi:10.1093/annonc/mdu312.5 · Cited by 1,169
(2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70077-9 · Cited by 1,132
Goss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji250 · Cited by 1,118
Gelmon, K. A., Tischkowitz, M., Mackay, H., Swenerton, K., Robidoux, A., Tonkin, K., Hirte, H., Huntsman, D., Clemons, M., Gilks, B., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70214-5 · Cited by 1,117
Jansson, M. D., & Lund, A. H. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.006 · Cited by 1,099
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
The Breast and Ovarian Cancer Susceptibility Collaboration, Michailidou, K., Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), kConFab Investigators, Australian Ovarian Cancer Study Group, The GENICA (Gene Environment Interaction and Breast Cancer in Germany) Network, Hall, P., Gonzalez-Neira, A., Ghoussaini, M., Dennis, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2563 · Cited by 1,069
Self-citationBaccelli, I., Schneeweiss, A., Riethdorf, S., Stenzinger, A., Schillert, A., Vogel, V., Klein, C., Saini, M., Bäuerle, T., Wallwiener, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2576 · Cited by 1,047
Bartelink, H., Horiot, J.-C., Poortmans, P. M., Struikmans, H., Van den Bogaert, W., Fourquet, A., Jager, J. J., Hoogenraad, W. J., Oei, S. B., Wárlám-Rodenhuis, C. C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.4991 · Cited by 1,047
Johnston, S., Pippen, J., Pivot, X., Lichinitser, M., Sadeghi, S., Dieras, V., Gomez, H. L., Romieu, G., Manikhas, A., Kennedy, M. J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.3734 · Cited by 1,025
Vinci, M., Gowan, S., Boxall, F., Patterson, L., Zimmermann, M., Court, W., Lomas, C., Mendiola, M., Hardisson, D., & Eccles, S. A. (2012) · BMC Biology · doi:10.1186/1741-7007-10-29 · Cited by 1,024
Self-citationEconomic burden of cancer across the European Union: a population-based cost analysis
Luengo-Fernandez, R., Leal, J., Gray, A., & Sullivan, R. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70442-x · Cited by 1,008
Swain, S. M., Kim, S.-B., Cortés, J., Ro, J., Semiglazov, V., Campone, M., Ciruelos, E., Ferrero, J.-M., Schneeweiss, A., Knott, A., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70130-x · Cited by 1,006
Heterogeneity in breast cancer
Polyak, K. (2011) · Journal of Clinical Investigation · doi:10.1172/jci60534 · Cited by 1,006
Exemestane for Breast-Cancer Prevention in Postmenopausal Women
Goss, P. E., Ingle, J. N., Alés-Martínez, J. E., Cheung, A. M., Chlebowski, R. T., Wactawski-Wende, J., McTiernan, A., Robbins, J., Johnson, K. C., Martin, L. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103507 · Cited by 970
Self-citationRottenberg, S., Jaspers, J. E., Kersbergen, A., van der Burg, E., Nygren, A. O. H., Zander, S. A. L., Derksen, P. W. B., de Bruin, M., Zevenhoven, J., Lau, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806092105 · Cited by 956
Dual Effects of Weight and Weight Gain on Breast Cancer Risk
Huang, Z., Hankinson, S. E., Colditz, G. A., Stampfer, M. J., Hunter, D. J., Manson, J. E., Hennekens, C. H., Rosner, B., Speizer, F. E., & Willett, W. C. (1997) · JAMA · doi:10.1001/jama.1997.03550170037029 · Cited by 950
Pece, S., Tosoni, D., Confalonieri, S., Mazzarol, G., Vecchi, M., Ronzoni, S., Bernard, L., Viale, G., Pelicci, P. G., & Di Fiore, P. P. (2010) · Cell · doi:10.1016/j.cell.2009.12.007 · Cited by 947
Coombes, R., Kilburn, L., Snowdon, C., Paridaens, R., Coleman, R., Jones, S., Jassem, J., Van de Velde, C., Delozier, T., Alvarez, I., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60200-1 · Cited by 907
Wiseman, M. (2008) · Proceedings of the Nutrition Society · doi:10.1017/s002966510800712x · Cited by 899
Triple-negative breast cancer: therapeutic options
Cleator, S., Heller, W., & Coombes, R. C. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70074-8 · Cited by 882
Cancer stem cells and epithelial–mesenchymal transition: Concepts and molecular links
Scheel, C., & Weinberg, R. A. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.04.001 · Cited by 881
Jakesz, R., Jonat, W., Gnant, M., Mittlboeck, M., Greil, R., Tausch, C., Hilfrich, J., Kwasny, W., Menzel, C., Samonigg, H., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67059-6 · Cited by 879
Chaffer, C. L., Marjanovic, N. D., Lee, T., Bell, G., Kleer, C. G., Reinhardt, F., D’Alessio, A. C., Young, R. A., & Weinberg, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.06.005 · Cited by 876
Smith, B. D., Arthur, D. W., Buchholz, T. A., Haffty, B. G., Hahn, C. A., Hardenbergh, P. H., Julian, T. B., Marks, L. B., Todor, D. A., Vicini, F. A., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.02.031 · Cited by 872
Distinct stem cells contribute to mammary gland development and maintenance
Van Keymeulen, A., Rocha, A. S., Ousset, M., Beck, B., Bouvencourt, G., Rock, J., Sharma, N., Dekoninck, S., & Blanpain, C. (2011) · Nature · doi:10.1038/nature10573 · Cited by 854
Fallowfield, L., Jenkins, V., Farewell, V., Saul, J., Duffy, A., & Eves, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07810-8 · Cited by 854
Prentice, R. L., Caan, B., Chlebowski, R. T., Patterson, R., Kuller, L. H., Ockene, J. K., Margolis, K. L., Limacher, M. C., Manson, J. E., Parker, L. M., et al. (2006) · JAMA · doi:10.1001/jama.295.6.629 · Cited by 828
Cancer Survivors in the United States: Age, Health, and Disability
Hewitt, M., Rowland, J. H., & Yancik, R. (2003) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/58.1.m82 · Cited by 785
Physical activity for cancer survivors: meta-analysis of randomised controlled trials
Fong, D. Y. T., Ho, J. W. C., Hui, B. P. H., Lee, A. M., Macfarlane, D. J., Leung, S. S. K., Cerin, E., Chan, W. Y. Y., Leung, I. P. F., Lam, S. H. S., et al. (2012) · BMJ · doi:10.1136/bmj.e70 · Cited by 782
Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update
Lacroix, M., & Leclercq, G. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000014042.54925.cc · Cited by 782
Vaidya, J. S., Joseph, D. J., Tobias, J. S., Bulsara, M., Wenz, F., Saunders, C., Alvarado, M., Flyger, H. L., Massarut, S., Eiermann, W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60837-9 · Cited by 772
Pierce, J. P., Natarajan, L., Caan, B. J., Parker, B. A., Greenberg, E. R., Flatt, S. W., Rock, C. L., Kealey, S., Al-Delaimy, W. K., Bardwell, W. A., et al. (2007) · JAMA · doi:10.1001/jama.298.3.289 · Cited by 734
Self-citationFGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
Turner, N., Pearson, A., Sharpe, R., Lambros, M., Geyer, F., Lopez-Garcia, M. A., Natrajan, R., Marchio, C., Iorns, E., Mackay, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3746 · Cited by 732
Self-citationDuncan, J. S., Whittle, M. C., Nakamura, K., Abell, A. N., Midland, A. A., Zawistowski, J. S., Johnson, N. L., Granger, D. A., Jordan, N. V., Darr, D. B., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.053 · Cited by 732
Gene expression profiling in breast cancer: classification, prognostication, and prediction
Reis-Filho, J. S., & Pusztai, L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61539-0 · Cited by 729
ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
Liu, X., Ory, V., Chapman, S., Yuan, H., Albanese, C., Kallakury, B., Timofeeva, O. A., Nealon, C., Dakic, A., Simic, V., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.10.036 · Cited by 726
Dowsett, M., Cuzick, J., Wale, C., Forbes, J., Mallon, E. A., Salter, J., Quinn, E., Dunbier, A., Baum, M., Buzdar, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.4798 · Cited by 724
Self-citationMetastasis: recent discoveries and novel treatment strategies
Eccles, S. A., & Welch, D. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60781-8 · Cited by 721
Self-citationJournal of Clinical Oncology: One Year Old and Growing
(1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.1.1 · Cited by 688
Parkin, D. M., Boyd, L., & Walker, L. C. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.489 · Cited by 663
Adult Weight Change and Risk of Postmenopausal Breast Cancer
Eliassen, A. H., Colditz, G. A., Rosner, B., Willett, W. C., & Hankinson, S. E. (2006) · JAMA · doi:10.1001/jama.296.2.193 · Cited by 654
The secreted factors responsible for pre-metastatic niche formation: Old sayings and new thoughts
Peinado, H., Lavotshkin, S., & Lyden, D. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.01.002 · Cited by 654
Tsai, H.-C., Li, H., Van Neste, L., Cai, Y., Robert, C., Rassool, F. V., Shin, J. J., Harbom, K. M., Beaty, R., Pappou, E., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.029 · Cited by 650
Iliopoulos, D., Hirsch, H. A., Wang, G., & Struhl, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018898108 · Cited by 643
Polgár, C., Limbergen, E. V., Pötter, R., Kovács, G., Polo, A., Lyczek, J., Hildebrandt, G., Niehoff, P., Guinot, J. L., Guedea, F., et al. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.01.014 · Cited by 633
Decoding global gene expression programs in liver cancer by noninvasive imaging
Segal, E., Sirlin, C. B., Ooi, C., Adler, A. S., Gollub, J., Chen, X., Chan, B. K., Matcuk, G. R., Barry, C. T., Chang, H. Y., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1306 · Cited by 629
Vascular permeability, vascular hyperpermeability and angiogenesis
Nagy, J. A., Benjamin, L., Zeng, H., Dvorak, A. M., & Dvorak, H. F. (2008) · Angiogenesis · doi:10.1007/s10456-008-9099-z · Cited by 628
Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes
Basch, E., Jia, X., Heller, G., Barz, A., Sit, L., Fruscione, M., Appawu, M., Iasonos, A., Atkinson, T., Goldfarb, S., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp386 · Cited by 624
Osborn, R. L., Demoncada, A. C., & Feuerstein, M. (2006) · The International Journal of Psychiatry in Medicine · doi:10.2190/eufn-rv1k-y3tr-fk0l · Cited by 621
Giampieri, S., Manning, C., Hooper, S., Jones, L., Hill, C. S., & Sahai, E. (2009) · Nature Cell Biology · doi:10.1038/ncb1973 · Cited by 601
Self-citationThe rationale for targeting the LOX family in cancer
Barker, H. E., Cox, T. R., & Erler, J. T. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3319 · Cited by 590
Armes, J., Crowe, M., Colbourne, L., Morgan, H., Murrells, T., Oakley, C., Palmer, N., Ream, E., Young, A., & Richardson, A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.5151 · Cited by 587 · cited 2×
“The current system does not meet their needs [184] and the National Cancer Survivorship Initiative has been established to investigate new models of aftercare.”
Self-citationDiscovery of small molecule cancer drugs: Successes, challenges and opportunities
Hoelder, S., Clarke, P. A., & Workman, P. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.02.004 · Cited by 587
Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis
Visvader, J. E. (2009) · Genes & Development · doi:10.1101/gad.1849509 · Cited by 571
Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women
Chlebowski, R. T., Anderson, G. L., Gass, M., Lane, D. S., Aragaki, A. K., Kuller, L. H., Manson, J. E., Stefanick, M. L., Ockene, J., Sarto, G. E., et al. (2010) · JAMA · doi:10.1001/jama.2010.1500 · Cited by 567
Gorges, T. M., Tinhofer, I., Drosch, M., Röse, L., Zollner, T. M., Krahn, T., & von Ahsen, O. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-178 · Cited by 565
Blackwell, K. L., Burstein, H. J., Storniolo, A. M., Rugo, H. S., Sledge, G., Aktan, G., Ellis, C., Florance, A., Vukelja, S., Bischoff, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.6725 · Cited by 547
Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor
Harrison, H., Farnie, G., Howell, S. J., Rock, R. E., Stylianou, S., Brennan, K. R., Bundred, N. J., & Clarke, R. B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1681 · Cited by 543
Self-citationClassen, C., Butler, L. D., Koopman, C., Miller, E., DiMiceli, S., Giese-Davis, J., Fobair, P., Carlson, R. W., Kraemer, H. C., & Spiegel, D. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.494 · Cited by 520
Solin, L. J., Gray, R., Baehner, F. L., Butler, S. M., Hughes, L. L., Yoshizawa, C., Cherbavaz, D. B., Shak, S., Page, D. L., Sledge, G. W., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt067 · Cited by 518
Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810818 · Cited by 496
Cuzick, J., Sestak, I., Bonanni, B., Costantino, J. P., Cummings, S., DeCensi, A., Dowsett, M., Forbes, J. F., Ford, L., LaCroix, A. Z., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60140-3 · Cited by 495
Fleissig, A., Fallowfield, L. J., Langridge, C. I., Johnson, L., Newcombe, R. G., Dixon, J. M., Kissin, M., & Mansel, R. E. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9025-7 · Cited by 494
Zhang, X., Claerhout, S., Prat, A., Dobrolecki, L. E., Petrovic, I., Lai, Q., Landis, M. D., Wiechmann, L., Schiff, R., Giuliano, M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4081 · Cited by 481
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Senkus, E., Kyriakides, S., Penault-Llorca, F., Poortmans, P., Thompson, A., Zackrisson, S., & Cardoso, F. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt284 · Cited by 479
Self-citationSubtype and pathway specific responses to anticancer compounds in breast cancer
Heiser, L. M., Sadanandam, A., Kuo, W.-L., Benz, S. C., Goldstein, T. C., Ng, S., Gibb, W. J., Wang, N. J., Ziyad, S., Tong, F., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018854108 · Cited by 475
Self-citationDissecting the Heterogeneity of Triple-Negative Breast Cancer
Metzger-Filho, O., Tutt, A., de Azambuja, E., Saini, K. S., Viale, G., Loi, S., Bradbury, I., Bliss, J. M., Azim, H. A., Ellis, P., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.2010 · Cited by 465
Self-citationAssessing Women at High Risk of Breast Cancer: A Review of Risk Assessment Models
Amir, E., Freedman, O. C., Seruga, B., & Evans, D. G. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq088 · Cited by 464
Self-citationvan Amerongen, R., Bowman, A. N., & Nusse, R. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.05.023 · Cited by 445
Projections of cancer prevalence in the United Kingdom, 2010–2040
Maddams, J., Utley, M., & Møller, H. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.366 · Cited by 440
Systematic review of peer-support programs for people with cancer
Hoey, L. M., Ieropoli, S. C., White, V. M., & Jefford, M. (2008) · Patient Education and Counseling · doi:10.1016/j.pec.2007.11.016 · Cited by 429
The pre-metastatic niche: finding common ground
Sceneay, J., Smyth, M. J., & Möller, A. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9420-1 · Cited by 422
Exosome removal as a therapeutic adjuvant in cancer
Marleau, A. M., Chen, C.-S., Joyce, J. A., & Tullis, R. H. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-134 · Cited by 411
Cuzick, J., Warwick, J., Pinney, E., Duffy, S. W., Cawthorn, S., Howell, A., Forbes, J. F., & Warren, R. M. L. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr079 · Cited by 405
Self-citationNeurocognitive Performance in Breast Cancer Survivors Exposed to Adjuvant Chemotherapy and Tamoxifen
Castellon, S. A., Ganz, P. A., Bower, J. E., Petersen, L., Abraham, L., & Greendale, G. A. (2004) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490510905 · Cited by 396
Kallergi, G., Papadaki, M. A., Politaki, E., Mavroudis, D., Georgoulias, V., & Agelaki, S. (2011) · Breast Cancer Research · doi:10.1186/bcr2896 · Cited by 377
Mouse models of advanced spontaneous metastasis for experimental therapeutics
Francia, G., Cruz-Munoz, W., Man, S., Xu, P., & Kerbel, R. S. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3001 · Cited by 374
Martin, L. J., & Boyd, N. F. (2008) · Breast Cancer Research · doi:10.1186/bcr1831 · Cited by 373
Self-citationTargeted therapies for breast cancer
Higgins, M. J., & Baselga, J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57152 · Cited by 369
Anderson, G. L., Chlebowski, R. T., Aragaki, A. K., Kuller, L. H., Manson, J. E., Gass, M., Bluhm, E., Connelly, S., Hubbell, F. A., Lane, D., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70075-x · Cited by 364
Self-citationAnti-VEGF/VEGFR Therapy for Cancer: Reassessing the Target
Sitohy, B., Nagy, J. A., & Dvorak, H. F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3406 · Cited by 360
Strategies for the discovery and development of therapies for metastatic breast cancer
Eckhardt, B. L., Francis, P. A., Parker, B. S., & Anderson, R. L. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd2372 · Cited by 349
Anti-angiogenesis therapy in cancer: Current challenges and future perspectives
Shojaei, F. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.008 · Cited by 348
Harvie, M., Howell, A., Vierkant, R. A., Kumar, N., Cerhan, J. R., Kelemen, L. E., Folsom, A. R., & Sellers, T. A. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0001 · Cited by 340
Self-citationPsychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis
Kissane, D. W., Grabsch, B., Love, A., Clarke, D. M., Bloch, S., & Smith, G. C. (2004) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2004.01358.x · Cited by 337 · cited 1×
“In addition, selfimage and a decrease in sexual functioning challenge selfesteem and relationships at a time when support is most needed [322].”
Pivot, X., Romieu, G., Debled, M., Pierga, J.-Y., Kerbrat, P., Bachelot, T., Lortholary, A., Espié, M., Fumoleau, P., Serin, D., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70225-0 · Cited by 337
The future of epigenetic therapy in solid tumours—lessons from the past
Azad, N., Zahnow, C. A., Rudin, C. M., & Baylin, S. B. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.42 · Cited by 335
Weigelt, B., Lo, A. T., Park, C. C., Gray, J. W., & Bissell, M. J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0502-2 · Cited by 334
Mimeault, M., & Batra, S. K. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12004 · Cited by 330
MicroRNA Cluster 221-222 and Estrogen Receptor α Interactions in Breast Cancer
Di Leva, G., Gasparini, P., Piovan, C., Ngankeu, A., Garofalo, M., Taccioli, C., Iorio, M. V., Li, M., Volinia, S., Alder, H., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq102 · Cited by 320
Radiation Therapy to Convert the Tumor Into an In Situ Vaccine
Formenti, S. C., & Demaria, S. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.06.020 · Cited by 319
DNA methylation in serum of breast cancer patients: an independent prognostic marker.
Müller, H. M., Widschwendter, A., Fiegl, H., Ivarsson, L., Goebel, G., Perkmann, E., Marth, C., & Widschwendter, M. (2003) · PubMed · Cited by 317
Clinical implications of cancer self-seeding
Comen, E., Norton, L., & Massagué, J. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.64 · Cited by 312
Mann, E., Smith, M. J., Hellier, J., Balabanovic, J. A., Hamed, H., Grunfeld, E. A., & Hunter, M. S. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70364-3 · Cited by 307
Self-citationA new genome‐driven integrated classification of breast cancer and its implications
Dawson, S., Rueda, O. M., Aparicio, S., & Caldas, C. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.19 · Cited by 306
Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice
Anisimov, V. N., Zabezhinski, M. A., Popovich, I. G., Piskunova, T. S., Semenchenko, A. V., Tyndyk, M. L., Yurova, M. N., Rosenfeld, S. V., & Blagosklonny, M. V. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18486 · Cited by 299
Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality
Makubate, B., Donnan, P. T., Dewar, J. A., Thompson, A. M., & McCowan, C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.116 · Cited by 298
Self-citationRitterband, L. M., Bailey, E. T., Thorndike, F. P., Lord, H. R., Farrell‐Carnahan, L., & Baum, L. D. (2012) · Psycho-Oncology · doi:10.1002/pon.1969 · Cited by 296 · cited 1×
“CBT reduces fatigue [339], insomnia [340] improves physical activity and quality of life [341].”
Hadad, S., Iwamoto, T., Jordan, L., Purdie, C., Bray, S., Baker, L., Jellema, G., Deharo, S., Hardie, D. G., Pusztai, L., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1612-1 · Cited by 293
Self-citationMartin, F. T., Dwyer, R. M., Kelly, J., Khan, S., Murphy, J. M., Curran, C., Miller, N., Hennessy, E., Dockery, P., Barry, F. P., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0734-1 · Cited by 290
Dixon, J. M. (2012) · Medical Entomology and Zoology · Cited by 287
Kasimir-Bauer, S., Hoffmann, O., Wallwiener, D., Kimmig, R., & Fehm, T. (2012) · Breast Cancer Research · doi:10.1186/bcr3099 · Cited by 284
What is the evidence for the use of mindfulness‐based interventions in cancer care? A review
Shennan, C., Payne, S., & Fenlon, D. (2011) · Psycho-Oncology · doi:10.1002/pon.1819 · Cited by 271 · cited 1×
“Mindfulness-based stress reduction and cognitive therapy can improve mood, endocrine-related quality of life, and wellbeing at least in the short term [345].”
Self-citationThe fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010
Peto, R. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.473 · Cited by 265
Physical Activity and Breast Cancer: Review of the Epidemiologic Evidence and Biologic Mechanisms
Friedenreich, C. M. (2010) · Recent Results in Cancer Research · doi:10.1007/978-3-642-10858-7_11 · Cited by 262
Epithelial-mesenchymal transition, cancer stem cells and treatment resistance
Dave, B., Mittal, V., Tan, N. M., & Chang, J. C. (2012) · Breast Cancer Research · doi:10.1186/bcr2938 · Cited by 257
Liauw, S. L., Connell, P. P., & Weichselbaum, R. R. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005148 · Cited by 257
Thompson, A. M., Jordan, L. B., Quinlan, P., Anderson, E., Skene, A., Dewar, J. A., Purdie, C. A., & the Breast Recurrence in Tissues Study Group (2010) · Breast Cancer Research · doi:10.1186/bcr2771 · Cited by 253
Self-citationNeoadjuvant treatment of breast cancer
Thompson, A. M., & Moulder-Thompson, S. L. (2012) · Annals of Oncology · doi:10.1093/annonc/mds324 · Cited by 251
Self-citationControversies in clinical cancer dormancy
Uhr, J. W., & Pantel, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106613108 · Cited by 251
Physical and Psychosocial Recovery in the Year After Primary Treatment of Breast Cancer
Ganz, P. A., Kwan, L., Stanton, A. L., Bower, J. E., & Belin, T. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.8043 · Cited by 251
Lymphangiogenesis and lymphatic metastasis in breast cancer
Ran, S., Volk, L., Hall, K., & Flister, M. J. (2010) · Pathophysiology · doi:10.1016/j.pathophys.2009.11.003 · Cited by 250
Recovery and self-management support following primary cancer treatment
Foster, C., & Fenlon, D. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.419 · Cited by 249
Self-citationPsychological interventions for women with metastatic breast cancer
Mustafa, M., Carson-Stevens, A., Gillespie, D., & Edwards, A. G. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004253.pub4 · Cited by 244 · cited 2×
“iety and depression than individualised interventions such as cognitive behaviour therapy (CBT); [334], but do”
BackgroundFOSTER, C., WRIGHT, D., HILL, H., HOPKINSON, J., & ROFFE, L. (2009) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2008.01001.x · Cited by 244
Self-citationCancer prevalence in the United Kingdom: estimates for 2008
Maddams, J., Brewster, D., Gavin, A., Steward, J., Elliott, J., Utley, M., & Møller, H. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605148 · Cited by 244
Insight into the heterogeneity of breast cancer through next-generation sequencing
Russnes, H. G., Navin, N., Hicks, J., & Borresen-Dale, A.-L. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57088 · Cited by 240
Phenotypic plasticity and epithelial‐mesenchymal transitions in cancer and normal stem cells?
Scheel, C., & Weinberg, R. A. (2011) · International Journal of Cancer · doi:10.1002/ijc.26311 · Cited by 233
Iorns, E., Turner, N. C., Elliott, R., Syed, N., Garrone, O., Gasco, M., Tutt, A. N. J., Crook, T., Lord, C. J., & Ashworth, A. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.001 · Cited by 230
Self-citationAndrogen receptor overexpression induces tamoxifen resistance in human breast cancer cells
De Amicis, F., Thirugnansampanthan, J., Cui, Y., Selever, J., Beyer, A., Parra, I., Weigel, N. L., Herynk, M. H., Tsimelzon, A., Lewis, M. T., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0436-8 · Cited by 230
Case–control study of shift-work and breast cancer risk in Danish nurses: Impact of shift systems
Hansen, J., & Stevens, R. G. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.07.005 · Cited by 226
DeRose, Y. S., Gligorich, K. M., Wang, G., Georgelas, A., Bowman, P., Courdy, S. J., Welm, A. L., & Welm, B. E. (2013) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph1423s60 · Cited by 226
Intracellular and Extracellular MicroRNAs in Breast Cancer
Corcoran, C., Friel, A. M., Duffy, M. J., Crown, J., & O'Driscoll, L. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.150730 · Cited by 225
Akhtar, N., & Streuli, C. H. (2013) · Nature Cell Biology · doi:10.1038/ncb2646 · Cited by 224
Self-citationBlamey, R. W., Bates, T., Chetty, U., Duffy, S. W., Ellis, I. O., George, D., Mallon, E., Mitchell, M. J., Monypenny, I., Morgan, D. A. L., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.02.031 · Cited by 222
Self-citationDuijts, S. F. A., van Beurden, M., Oldenburg, H. S. A., Hunter, M. S., Kieffer, J. M., Stuiver, M. M., Gerritsma, M. A., Menke-Pluymers, M. B. E., Plaisier, P. W., Rijna, H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.8525 · Cited by 220
Self-citationGiordano, A., Gao, H., Anfossi, S., Cohen, E., Mego, M., Lee, B.-N., Tin, S., De Laurentiis, M., Parker, C. A., Alvarez, R. H., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0460 · Cited by 219
Prevalence and Treatment Patterns of Physical Impairments in Patients With Metastatic Breast Cancer
Cheville, A. L., Troxel, A. B., Basford, J. R., & Kornblith, A. B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.3075 · Cited by 218
Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy
Chew, V., Toh, H. C., & Abastado, J.-P. (2012) · Journal of Oncology · doi:10.1155/2012/608406 · Cited by 218
The Effect of Seated Exercise on Fatigue and Quality of Life in Women With Advanced Breast Cancer
Headley, J. A., Ownby, K. K., & John, L. D. (2004) · Oncology Nursing Forum · doi:10.1188/04.onf.977-983 · Cited by 217
The role of the organ microenvironment in brain metastasis
Fidler, I. J. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.12.009 · Cited by 217
Mapping the quality of life and unmet needs of urban women with metastatic breast cancer
ARANDA, S., SCHOFIELD, P., WEIH, L., YATES, P., MILNE, D., FAULKNER, R., & VOUDOURIS, N. (2005) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2005.00541.x · Cited by 215
Cancer stem cells and metastasis
Sampieri, K., & Fodde, R. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.03.002 · Cited by 215
Current Protocols in Pharmacology
(2018) · Current Protocols in Pharmacology · doi:10.1002/(issn)1934-8290 · Cited by 213
Advances in Immuno–Positron Emission Tomography: Antibodies for Molecular Imaging in Oncology
Knowles, S. M., & Wu, A. M. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.4887 · Cited by 209
The role of tumor-associated macrophages in breast cancer progression
OBEID, E., NANDA, R., FU, Y.-X., & OLOPADE, O. I. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1938 · Cited by 204
Santen, R. J., Boyd, N. F., Chlebowski, R. T., Cummings, S., Cuzick, J., Dowsett, M., Easton, D., Forbes, J. F., Key, T., Hankinson, S. E., et al. (2007) · Endocrine-Related Cancer · doi:10.1677/erc-06-0045 · Cited by 203
Self-citationInflammation and breast cancer
Constantinou, C., & Fentiman, I. S. (2013) · Breast Cancer Management · doi:10.2217/bmt.13.26 · Cited by 196
Takebe, N., Warren, R. Q., & Ivy, S. P. (2011) · Breast Cancer Research · doi:10.1186/bcr2876 · Cited by 195
Tan, E. Y., Yan, M., Campo, L., Han, C., Takano, E., Turley, H., Candiloro, I., Pezzella, F., Gatter, K. C., Millar, E. K. A., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604844 · Cited by 195
Andre, F., Dieci, M. V., Dubsky, P., Sotiriou, C., Curigliano, G., Denkert, C., & Loi, S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2701 · Cited by 195
Paterson, A. H., Anderson, S. J., Lembersky, B. C., Fehrenbacher, L., Falkson, C. I., King, K. M., Weir, L. M., Brufsky, A. M., Dakhil, S., Lad, T., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70226-7 · Cited by 194
Bartlett, J. M. S., Brookes, C. L., Robson, T., van de Velde, C. J. H., Billingham, L. J., Campbell, F. M., Grant, M., Hasenburg, A., Hille, E. T. M., Kay, C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.3677 · Cited by 193
Müller, V., Riethdorf, S., Rack, B., Janni, W., Fasching, P. A., Solomayer, E., Aktas, B., Kasimir-Bauer, S., Pantel, K., & Fehm, T. (2012) · Breast Cancer Research · doi:10.1186/bcr3243 · Cited by 191
Niraula, S., Ocana, A., Ennis, M., & Goodwin, P. J. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2073-x · Cited by 189
Hopwood, P., Howell, A., & Maguire, P. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.304 · Cited by 189
Self-citationKievit, F. M., Stephen, Z. R., Veiseh, O., Arami, H., Wang, T., Lai, V. P., Park, J. O., Ellenbogen, R. G., Disis, M. L., & Zhang, M. (2012) · ACS Nano · doi:10.1021/nn205070h · Cited by 188
Fruit and vegetable intake and risk of breast cancer by hormone receptor status
Jung, S., Spiegelman, D., Baglietto, L., Bernstein, L., Boggs, D. A., van den Brandt, P. A., Buring, J. E., Cerhan, J. R., Gaudet, M. M., Giles, G. G., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs635 · Cited by 183 · cited 1×
“The risk of ER-ve tumours may be reduced by high vegetable intake [56] while lowering fat intake may reduce both breast cancer risk and relapse after surgery.”
Chivers Seymour, K., Addington‐Hall, J., Lucassen, A. M., & Foster, C. L. (2010) · Journal of Genetic Counseling · doi:10.1007/s10897-010-9296-y · Cited by 183
Self-citationNew strategies for targeting the hypoxic tumour microenvironment in breast cancer
Ward, C., Langdon, S. P., Mullen, P., Harris, A. L., Harrison, D. J., Supuran, C. T., & Kunkler, I. H. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.08.004 · Cited by 181
Self-citationOsborne, C. K., Neven, P., Dirix, L. Y., Mackey, J. R., Robert, J., Underhill, C., Schiff, R., Gutierrez, C., Migliaccio, I., Anagnostou, V. K., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1869 · Cited by 179
Cited by
Risk determination and prevention of breast cancer
Howell, A., Anderson, A. S., Clarke, R. B., Duffy, S. W., Evans, D. G., Garcia-Closas, M., Gescher, A. J., Key, T. J., Saxton, J. M., & Harvie, M. N. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0446-2 · Cited by 327
Self-citationTargeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease
Kalimutho, M., Parsons, K., Mittal, D., López, J. A., Srihari, S., & Khanna, K. K. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.08.009 · Cited by 294
Juvet, L. K., Thune, I., Elvsaas, I. K. Ø., Fors, E. A., Lundgren, S., Bertheussen, G., Leivseth, G., & Oldervoll, L. M. (2017) · The Breast · doi:10.1016/j.breast.2017.04.003 · Cited by 288
Saxton, J. M., Scott, E. J., Daley, A. J., Woodroofe, M. N., Mutrie, N., Crank, H., Powers, H. J., & Coleman, R. E. (2014) · Breast Cancer Research · doi:10.1186/bcr3643 · Cited by 111
Self-citationEvans, D. G. R., van Veen, E. M., Byers, H. J., Wallace, A. J., Ellingford, J. M., Beaman, G., Santoyo-Lopez, J., Aitman, T. J., Eccles, D. M., Lalloo, F. I., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.07.002 · Cited by 95
Self-citation
Metadata
- Authors
- Eccles, S. A., Aboagye, E. O., Ali, S., Anderson, A. S., Armes, J., Berditchevski, F., Blaydes, J. P., Brennan, K., Brown, N. J., Bryant, H. E., Bundred, N. J., Burchell, J. M., Campbell, A. M., Carroll, J. S., Clarke, R. B., Coles, C. E., Cook, G. J., Cox, A., Curtin, N. J., Dekker, L. V., dos Santos Silva, I., Duffy, S. W., Easton, D. F., Eccles, D. M., Edwards, D. R., Edwards, J., Evans, D. G., Fenlon, D. F., Flanagan, J. M., Foster, C., Gallagher, W. M., Garcia-Closas, M., Gee, J. M. W., Gescher, A. J., Goh, V., Groves, A. M., Harvey, A. J., Harvie, M., Hennessy, B. T., Hiscox, S., Holen, I., Howell, S. J., Howell, A., Hubbard, G., Hulbert-Williams, N., Hunter, M. S., Jasani, B., Jones, L. J., Key, T. J., Kirwan, C. C., Kong, A., Kunkler, I. H., Langdon, S. P., Leach, M. O., Mann, D. J., Marshall, J. F., Martin, L. A., Martin, S. G., Macdougall, J. E., Miles, D. W., Miller, W. R., Morris, J. R., Moss, S. M., Mullan, P., Natrajan, R., O’Connor, J. P., O’Connor, R., Palmieri, C., Pharoah, P. D. P., Rakha, E. A., Reed, E., Robinson, S. P., Sahai, E., Saxton, J. M., Schmid, P., Smalley, M. J., Speirs, V., Stein, R., Stingl, J., Streuli, C. H., Tutt, A. N. J., Velikova, G., Walker, R. A., Watson, C. J., Williams, K. J., Young, L. S., & Thompson, A. M.
- Venue
- Breast Cancer Research
- Published
- 2013-10-01
- Volume
- 15
- Issue
- 5
- Pages
- R92-R92
- ISSN
- 1465-5411 (ISSN-L)
- 1465-542X
- OpenAlex
- W2095783009
- Cited by
- 421
- References
- 379
- FWCI
- 12.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.